# Implementasi Use Case Vaksinasi COVID-19
*Last Updated: 2023/12/27*

## A. Pendahuluan
<div style="margin-left: 30px;">
<p>
Vaksinasi memiliki peran yang sangat penting dalam menangani pandemi COVID-19. Vaksinasi COVID-19 secara umum bertujuan untuk:
<ol>
<li>Melindungi Kesehatan Individu: Vaksin COVID-19 efektif dalam melindungi individu dari penyakit yang parah, komplikasi serius, dan risiko kematian akibat COVID-19. Dengan menerima vaksin, individu dapat mengurangi risiko mereka terkena penyakit yang membutuhkan perawatan medis intensif dan mengalami dampak jangka panjang pada kesehatan mereka.</li>
<li>Mencegah Penyebaran Penyakit: Vaksinasi COVID-19 membantu mencegah penyebaran virus SARS-CoV-2 yang menyebabkan COVID-19. Dengan mengurangi jumlah orang yang rentan terhadap infeksi, vaksinasi membantu menghentikan rantai penularan dan memutus mata rantai penyebaran virus.</li>
<li>Melindungi Masyarakat: Vaksinasi COVID-19 juga melindungi masyarakat secara keseluruhan. Ketika cukup banyak orang divaksinasi, tercipta kekebalan komunal atau herd immunity. Hal ini melibatkan perlindungan bagi mereka yang tidak dapat atau belum divaksinasi, seperti anak-anak yang belum memenuhi syarat untuk vaksinasi atau orang dengan sistem kekebalan yang lemah. Herd immunity membantu membatasi penyebaran virus di komunitas dan melindungi kelompok rentan.</li>
</ol>
</p>

<p>Selain dari proses vaksinasi itu sendiri, proses pelaporan data vaksinasi yang menyertai juga tidak kalah penting. Dalam skala nasional, proses pelaporan dan juga pengumpulan data berperan penting dalam proses perencanaan logistik vaksin yang berbasis data, proses monitoring dan evaluasi dari program vaksinasi, proses pemantauan kejadian ikutan pasca imunisasi, dan juga sebagai dasar dari berbagai kegiatan pengembangan dan pengambilan keputusan berbasis data. Oleh karena itu, proses pelaporan data vaksinasi yang tepat, akurat, dan cepat adalah suatu hal yang sangat penting.</p>

<p>Untuk itu, proses integrasi dari data vaksinasi dengan SATUSEHAT adalah salah satu proses dasar yang penting dalam kegiatan vaksinasi COVID-19. Dalam ini, tahapan alur integrasi dan resource yang digunakan untuk integrasi pelaporan vaksinasi COVID-19 dapat dilihat pada gambar dibawah ini.</p>

<center>
{{render:covid-vaksin-vaksin-skema}}

*Gambar 1. Alur Integrasi Vaksinasi COVID-19*
</center>

## Referensi:

<table style="background-color: #f6f8f8; border-radius: 10px;">
    <tr>
         <td style="padding: 10px 20px; width: 33%; vertical-align: top;">Postman Vaksinasi COVID-19</td>
        <td style="padding: 10px 20px; ; width: 33%; vertical-align: top;">Playbook Vaksinasi COVID-19 </td>
        <td style="padding: 10px 20px; ; width: 33%; vertical-align: top;">Postman Resume Medis Rawat Jalan SATUSEHAT</td>
    </tr>
    <tr>
        <td style="padding: 10px 20px; ;"><div style="background-color: lightblue; display: inline-block; border-radius: 4px; cursor: pointer; height: 32px; border: none; width: 123px; background-image: url('data:image/svg+xml;base64,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');" onclick="window.open('https://drive.google.com/file/d/10toxyWErjBKpB4-j4JILqfHwGAiPXyki/view?usp=drive_link', '_blank');"></div></td>
        <td style="padding: 10px 20px; ;"><div style="display: inline-block; border-radius: 4px; cursor: pointer; height: 32px; border: none; width: 123px; background-image: url('data:image/svg+xml;base64,<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" width="125" zoomAndPan="magnify" viewBox="0 0 93.75 30.000001" height="40" preserveAspectRatio="xMidYMid meet" version="1.0"><defs><g/><clipPath id="a7d2e34f6a"><path d="M 1.957031 1.246094 L 91.96875 1.246094 L 91.96875 23.878906 L 1.957031 23.878906 Z M 1.957031 1.246094 " clip-rule="nonzero"/></clipPath><clipPath id="70ab78da36"><path d="M 4.140625 1.246094 L 89.609375 1.246094 C 90.816406 1.246094 91.792969 2.222656 91.792969 3.429688 L 91.792969 21.519531 C 91.792969 22.726562 90.816406 23.703125 89.609375 23.703125 L 4.140625 23.703125 C 2.933594 23.703125 1.957031 22.726562 1.957031 21.519531 L 1.957031 3.429688 C 1.957031 2.222656 2.933594 1.246094 4.140625 1.246094 " clip-rule="nonzero"/></clipPath><clipPath id="37809d1fea"><path d="M 16.113281 7.207031 L 17.957031 7.207031 L 17.957031 9.027344 L 16.113281 9.027344 Z M 16.113281 7.207031 " clip-rule="nonzero"/></clipPath><clipPath id="345c01d24f"><path d="M 10.679688 7.199219 L 17.957031 7.199219 L 17.957031 17.390625 L 10.679688 17.390625 Z M 10.679688 7.199219 " clip-rule="nonzero"/></clipPath></defs><g clip-path="url(#a7d2e34f6a)"><g clip-path="url(#70ab78da36)"><path fill="#47b08b" d="M 1.957031 1.246094 L 91.96875 1.246094 L 91.96875 23.878906 L 1.957031 23.878906 Z M 1.957031 1.246094 " fill-opacity="1" fill-rule="nonzero"/></g></g><g clip-path="url(#37809d1fea)"><path fill="#ffffff" d="M 16.136719 7.207031 L 16.199219 7.207031 L 16.273438 7.234375 L 16.351562 7.265625 L 17.890625 8.765625 L 17.957031 8.828125 L 17.957031 9.007812 L 16.136719 9.007812 L 16.136719 7.207031 " fill-opacity="1" fill-rule="evenodd"/></g><g clip-path="url(#345c01d24f)"><path fill="#ffffff" d="M 10.890625 7.207031 L 15.921875 7.207031 L 15.921875 9.21875 L 17.957031 9.21875 L 17.957031 17.386719 L 10.679688 17.386719 L 10.679688 7.207031 Z M 12.554688 9.550781 C 12.023438 9.875 11.679688 10.382812 11.546875 10.9375 C 11.414062 11.496094 11.496094 12.101562 11.824219 12.625 C 12.152344 13.152344 12.664062 13.496094 13.226562 13.625 C 13.628906 13.71875 14.054688 13.703125 14.457031 13.570312 L 16.09375 16.183594 C 16.160156 16.292969 16.257812 16.371094 16.359375 16.414062 C 16.484375 16.464844 16.621094 16.464844 16.734375 16.394531 L 16.882812 16.304688 C 16.996094 16.234375 17.058594 16.113281 17.066406 15.980469 C 17.074219 15.871094 17.042969 15.75 16.976562 15.640625 L 15.339844 13.027344 C 15.640625 12.726562 15.84375 12.355469 15.9375 11.960938 C 16.070312 11.402344 15.988281 10.796875 15.660156 10.273438 C 15.332031 9.746094 14.820312 9.402344 14.257812 9.273438 C 13.695312 9.144531 13.082031 9.226562 12.554688 9.550781 Z M 14.421875 13.132812 L 14.460938 13.113281 C 14.496094 13.101562 14.527344 13.085938 14.554688 13.074219 L 14.554688 13.070312 C 14.566406 13.066406 14.574219 13.0625 14.585938 13.054688 C 14.625 13.035156 14.660156 13.015625 14.691406 12.996094 C 14.695312 12.996094 14.699219 12.992188 14.707031 12.988281 C 14.757812 12.957031 14.808594 12.921875 14.855469 12.886719 C 14.878906 12.867188 14.902344 12.847656 14.925781 12.828125 L 14.953125 12.804688 C 15.242188 12.554688 15.4375 12.222656 15.523438 11.863281 C 15.628906 11.410156 15.5625 10.917969 15.296875 10.496094 C 15.03125 10.070312 14.617188 9.792969 14.160156 9.6875 C 13.703125 9.582031 13.207031 9.644531 12.777344 9.910156 C 12.351562 10.171875 12.070312 10.582031 11.960938 11.035156 C 11.855469 11.488281 11.921875 11.980469 12.1875 12.402344 C 12.453125 12.828125 12.867188 13.105469 13.324219 13.210938 C 13.683594 13.296875 14.066406 13.273438 14.421875 13.132812 " fill-opacity="1" fill-rule="evenodd"/></g><path fill="#212121" d="M 16.507812 16.035156 L 16.523438 16.023438 C 16.523438 16.023438 16.496094 16.042969 16.507812 16.035156 " fill-opacity="1" fill-rule="nonzero"/><path fill="#212121" d="M 16.65625 15.945312 C 16.667969 15.9375 16.640625 15.953125 16.640625 15.953125 L 16.65625 15.945312 " fill-opacity="1" fill-rule="nonzero"/><g fill="#ffffff" fill-opacity="1"><g transform="translate(21.594829, 15.960062)"><g><path d="M 6.390625 -6.515625 L 3.765625 0 L 2.546875 0 L -0.078125 -6.515625 L 1 -6.515625 C 1.125 -6.515625 1.222656 -6.488281 1.296875 -6.4375 C 1.367188 -6.382812 1.421875 -6.3125 1.453125 -6.21875 L 2.859375 -2.46875 C 2.921875 -2.320312 2.976562 -2.164062 3.03125 -2 C 3.082031 -1.832031 3.128906 -1.660156 3.171875 -1.484375 C 3.210938 -1.660156 3.253906 -1.832031 3.296875 -2 C 3.347656 -2.164062 3.398438 -2.320312 3.453125 -2.46875 L 4.859375 -6.21875 C 4.878906 -6.289062 4.925781 -6.359375 5 -6.421875 C 5.082031 -6.484375 5.179688 -6.515625 5.296875 -6.515625 Z M 6.390625 -6.515625 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(27.901463, 15.960062)"><g><path d="M 1.78125 -4.625 L 1.78125 0 L 0.546875 0 L 0.546875 -4.625 Z M 1.9375 -5.953125 C 1.9375 -5.847656 1.914062 -5.75 1.875 -5.65625 C 1.832031 -5.5625 1.773438 -5.476562 1.703125 -5.40625 C 1.628906 -5.34375 1.546875 -5.289062 1.453125 -5.25 C 1.359375 -5.21875 1.257812 -5.203125 1.15625 -5.203125 C 1.050781 -5.203125 0.953125 -5.21875 0.859375 -5.25 C 0.773438 -5.289062 0.695312 -5.34375 0.625 -5.40625 C 0.550781 -5.476562 0.492188 -5.5625 0.453125 -5.65625 C 0.421875 -5.75 0.40625 -5.847656 0.40625 -5.953125 C 0.40625 -6.054688 0.421875 -6.148438 0.453125 -6.234375 C 0.492188 -6.328125 0.550781 -6.40625 0.625 -6.46875 C 0.695312 -6.539062 0.773438 -6.597656 0.859375 -6.640625 C 0.953125 -6.679688 1.050781 -6.703125 1.15625 -6.703125 C 1.257812 -6.703125 1.359375 -6.679688 1.453125 -6.640625 C 1.546875 -6.597656 1.628906 -6.539062 1.703125 -6.46875 C 1.773438 -6.40625 1.832031 -6.328125 1.875 -6.234375 C 1.914062 -6.148438 1.9375 -6.054688 1.9375 -5.953125 Z M 1.9375 -5.953125 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(30.237254, 15.960062)"><g><path d="M 3.453125 -2.859375 C 3.453125 -2.992188 3.429688 -3.117188 3.390625 -3.234375 C 3.359375 -3.347656 3.304688 -3.445312 3.234375 -3.53125 C 3.160156 -3.625 3.066406 -3.695312 2.953125 -3.75 C 2.835938 -3.800781 2.703125 -3.828125 2.546875 -3.828125 C 2.242188 -3.828125 2.007812 -3.742188 1.84375 -3.578125 C 1.675781 -3.410156 1.566406 -3.171875 1.515625 -2.859375 Z M 1.5 -2.125 C 1.539062 -1.6875 1.664062 -1.367188 1.875 -1.171875 C 2.082031 -0.972656 2.351562 -0.875 2.6875 -0.875 C 2.851562 -0.875 3 -0.894531 3.125 -0.9375 C 3.25 -0.976562 3.359375 -1.019531 3.453125 -1.0625 C 3.546875 -1.113281 3.628906 -1.160156 3.703125 -1.203125 C 3.785156 -1.242188 3.863281 -1.265625 3.9375 -1.265625 C 4.03125 -1.265625 4.109375 -1.226562 4.171875 -1.15625 L 4.53125 -0.703125 C 4.394531 -0.546875 4.242188 -0.414062 4.078125 -0.3125 C 3.921875 -0.21875 3.757812 -0.140625 3.59375 -0.078125 C 3.425781 -0.0234375 3.253906 0.0078125 3.078125 0.03125 C 2.898438 0.0507812 2.734375 0.0625 2.578125 0.0625 C 2.253906 0.0625 1.953125 0.0078125 1.671875 -0.09375 C 1.390625 -0.195312 1.144531 -0.351562 0.9375 -0.5625 C 0.726562 -0.769531 0.5625 -1.023438 0.4375 -1.328125 C 0.320312 -1.640625 0.265625 -2 0.265625 -2.40625 C 0.265625 -2.726562 0.316406 -3.023438 0.421875 -3.296875 C 0.523438 -3.578125 0.671875 -3.820312 0.859375 -4.03125 C 1.054688 -4.238281 1.296875 -4.398438 1.578125 -4.515625 C 1.859375 -4.640625 2.171875 -4.703125 2.515625 -4.703125 C 2.816406 -4.703125 3.09375 -4.65625 3.34375 -4.5625 C 3.59375 -4.46875 3.804688 -4.328125 3.984375 -4.140625 C 4.171875 -3.960938 4.3125 -3.742188 4.40625 -3.484375 C 4.507812 -3.222656 4.5625 -2.925781 4.5625 -2.59375 C 4.5625 -2.5 4.554688 -2.421875 4.546875 -2.359375 C 4.535156 -2.296875 4.519531 -2.25 4.5 -2.21875 C 4.476562 -2.1875 4.445312 -2.160156 4.40625 -2.140625 C 4.375 -2.128906 4.332031 -2.125 4.28125 -2.125 Z M 1.5 -2.125 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(35.052576, 15.960062)"><g><path d="M 7.21875 -4.625 L 5.765625 0 L 4.765625 0 C 4.710938 0 4.664062 -0.015625 4.625 -0.046875 C 4.582031 -0.078125 4.550781 -0.132812 4.53125 -0.21875 L 3.78125 -2.71875 C 3.75 -2.8125 3.722656 -2.90625 3.703125 -3 C 3.679688 -3.101562 3.660156 -3.203125 3.640625 -3.296875 C 3.617188 -3.203125 3.597656 -3.101562 3.578125 -3 C 3.554688 -2.90625 3.53125 -2.8125 3.5 -2.71875 L 2.734375 -0.21875 C 2.691406 -0.0703125 2.601562 0 2.46875 0 L 1.515625 0 L 0.046875 -4.625 L 1.046875 -4.625 C 1.128906 -4.625 1.203125 -4.601562 1.265625 -4.5625 C 1.328125 -4.519531 1.367188 -4.46875 1.390625 -4.40625 L 1.96875 -2.109375 C 2 -1.960938 2.023438 -1.820312 2.046875 -1.6875 C 2.078125 -1.550781 2.109375 -1.414062 2.140625 -1.28125 C 2.171875 -1.414062 2.207031 -1.550781 2.25 -1.6875 C 2.289062 -1.820312 2.332031 -1.960938 2.375 -2.109375 L 3.0625 -4.421875 C 3.082031 -4.484375 3.117188 -4.535156 3.171875 -4.578125 C 3.234375 -4.617188 3.304688 -4.640625 3.390625 -4.640625 L 3.9375 -4.640625 C 4.019531 -4.640625 4.09375 -4.617188 4.15625 -4.578125 C 4.21875 -4.535156 4.257812 -4.484375 4.28125 -4.421875 L 4.9375 -2.109375 C 4.976562 -1.972656 5.015625 -1.832031 5.046875 -1.6875 C 5.085938 -1.550781 5.128906 -1.410156 5.171875 -1.265625 C 5.191406 -1.410156 5.210938 -1.550781 5.234375 -1.6875 C 5.265625 -1.820312 5.300781 -1.960938 5.34375 -2.109375 L 5.9375 -4.40625 C 5.957031 -4.46875 6 -4.519531 6.0625 -4.5625 C 6.125 -4.601562 6.195312 -4.625 6.28125 -4.625 Z M 7.21875 -4.625 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(42.324968, 15.960062)"><g/></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(44.458624, 15.960062)"><g><path d="M 2.890625 -3.28125 C 3.304688 -3.28125 3.613281 -3.378906 3.8125 -3.578125 C 4.007812 -3.785156 4.109375 -4.066406 4.109375 -4.421875 C 4.109375 -4.578125 4.082031 -4.722656 4.03125 -4.859375 C 3.976562 -4.992188 3.898438 -5.109375 3.796875 -5.203125 C 3.703125 -5.296875 3.578125 -5.367188 3.421875 -5.421875 C 3.273438 -5.472656 3.097656 -5.5 2.890625 -5.5 L 2.03125 -5.5 L 2.03125 -3.28125 Z M 2.890625 -6.515625 C 3.328125 -6.515625 3.707031 -6.460938 4.03125 -6.359375 C 4.363281 -6.253906 4.632812 -6.109375 4.84375 -5.921875 C 5.050781 -5.734375 5.203125 -5.507812 5.296875 -5.25 C 5.398438 -5 5.453125 -4.722656 5.453125 -4.421875 C 5.453125 -4.097656 5.398438 -3.800781 5.296875 -3.53125 C 5.191406 -3.269531 5.03125 -3.039062 4.8125 -2.84375 C 4.601562 -2.65625 4.335938 -2.503906 4.015625 -2.390625 C 3.691406 -2.285156 3.316406 -2.234375 2.890625 -2.234375 L 2.03125 -2.234375 L 2.03125 0 L 0.6875 0 L 0.6875 -6.515625 Z M 2.890625 -6.515625 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(50.091471, 15.960062)"><g><path d="M 1.765625 -6.703125 L 1.765625 0 L 0.515625 0 L 0.515625 -6.703125 Z M 1.765625 -6.703125 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(52.373359, 15.960062)"><g><path d="M 2.9375 -1.9375 C 2.632812 -1.914062 2.378906 -1.882812 2.171875 -1.84375 C 1.972656 -1.8125 1.8125 -1.765625 1.6875 -1.703125 C 1.570312 -1.648438 1.488281 -1.582031 1.4375 -1.5 C 1.394531 -1.425781 1.375 -1.347656 1.375 -1.265625 C 1.375 -1.078125 1.421875 -0.945312 1.515625 -0.875 C 1.617188 -0.800781 1.757812 -0.765625 1.9375 -0.765625 C 2.144531 -0.765625 2.320312 -0.800781 2.46875 -0.875 C 2.625 -0.945312 2.78125 -1.0625 2.9375 -1.21875 Z M 0.40625 -3.984375 C 0.675781 -4.234375 0.976562 -4.414062 1.3125 -4.53125 C 1.644531 -4.65625 2 -4.71875 2.375 -4.71875 C 2.65625 -4.71875 2.90625 -4.671875 3.125 -4.578125 C 3.34375 -4.492188 3.523438 -4.367188 3.671875 -4.203125 C 3.828125 -4.046875 3.941406 -3.859375 4.015625 -3.640625 C 4.097656 -3.421875 4.140625 -3.175781 4.140625 -2.90625 L 4.140625 0 L 3.578125 0 C 3.460938 0 3.375 -0.015625 3.3125 -0.046875 C 3.25 -0.078125 3.195312 -0.144531 3.15625 -0.25 L 3.0625 -0.546875 C 2.945312 -0.453125 2.832031 -0.363281 2.71875 -0.28125 C 2.613281 -0.207031 2.5 -0.144531 2.375 -0.09375 C 2.257812 -0.0390625 2.132812 0 2 0.03125 C 1.875 0.0625 1.726562 0.078125 1.5625 0.078125 C 1.351562 0.078125 1.164062 0.0507812 1 0 C 0.832031 -0.0625 0.6875 -0.144531 0.5625 -0.25 C 0.445312 -0.351562 0.351562 -0.484375 0.28125 -0.640625 C 0.21875 -0.804688 0.1875 -0.988281 0.1875 -1.1875 C 0.1875 -1.363281 0.226562 -1.535156 0.3125 -1.703125 C 0.40625 -1.878906 0.554688 -2.035156 0.765625 -2.171875 C 0.972656 -2.304688 1.253906 -2.421875 1.609375 -2.515625 C 1.960938 -2.609375 2.40625 -2.660156 2.9375 -2.671875 L 2.9375 -2.90625 C 2.9375 -3.195312 2.875 -3.410156 2.75 -3.546875 C 2.625 -3.679688 2.445312 -3.75 2.21875 -3.75 C 2.050781 -3.75 1.910156 -3.726562 1.796875 -3.6875 C 1.679688 -3.65625 1.578125 -3.613281 1.484375 -3.5625 C 1.398438 -3.519531 1.320312 -3.476562 1.25 -3.4375 C 1.175781 -3.394531 1.09375 -3.375 1 -3.375 C 0.90625 -3.375 0.828125 -3.394531 0.765625 -3.4375 C 0.710938 -3.476562 0.664062 -3.53125 0.625 -3.59375 Z M 0.40625 -3.984375 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(56.973069, 15.960062)"><g><path d="M 4.8125 -4.625 L 2.3125 1.25 C 2.269531 1.332031 2.21875 1.394531 2.15625 1.4375 C 2.101562 1.476562 2.019531 1.5 1.90625 1.5 L 0.984375 1.5 L 1.859375 -0.375 L 0 -4.625 L 1.09375 -4.625 C 1.1875 -4.625 1.257812 -4.601562 1.3125 -4.5625 C 1.363281 -4.519531 1.40625 -4.46875 1.4375 -4.40625 L 2.3125 -2.1875 C 2.34375 -2.101562 2.367188 -2.015625 2.390625 -1.921875 C 2.421875 -1.835938 2.445312 -1.753906 2.46875 -1.671875 C 2.53125 -1.847656 2.59375 -2.023438 2.65625 -2.203125 L 3.484375 -4.40625 C 3.503906 -4.46875 3.546875 -4.519531 3.609375 -4.5625 C 3.671875 -4.601562 3.738281 -4.625 3.8125 -4.625 Z M 4.8125 -4.625 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(61.752453, 15.960062)"><g><path d="M 1.75 -1.21875 C 1.863281 -1.082031 1.988281 -0.988281 2.125 -0.9375 C 2.269531 -0.882812 2.414062 -0.859375 2.5625 -0.859375 C 2.707031 -0.859375 2.84375 -0.882812 2.96875 -0.9375 C 3.09375 -1 3.195312 -1.085938 3.28125 -1.203125 C 3.375 -1.328125 3.445312 -1.484375 3.5 -1.671875 C 3.550781 -1.867188 3.578125 -2.109375 3.578125 -2.390625 C 3.578125 -2.628906 3.554688 -2.832031 3.515625 -3 C 3.472656 -3.175781 3.410156 -3.320312 3.328125 -3.4375 C 3.253906 -3.550781 3.160156 -3.628906 3.046875 -3.671875 C 2.941406 -3.722656 2.816406 -3.75 2.671875 -3.75 C 2.472656 -3.75 2.300781 -3.707031 2.15625 -3.625 C 2.019531 -3.539062 1.882812 -3.414062 1.75 -3.25 Z M 1.75 -4.09375 C 1.9375 -4.28125 2.140625 -4.425781 2.359375 -4.53125 C 2.578125 -4.644531 2.828125 -4.703125 3.109375 -4.703125 C 3.367188 -4.703125 3.601562 -4.648438 3.8125 -4.546875 C 4.03125 -4.441406 4.210938 -4.289062 4.359375 -4.09375 C 4.515625 -3.894531 4.632812 -3.65625 4.71875 -3.375 C 4.800781 -3.09375 4.84375 -2.78125 4.84375 -2.4375 C 4.84375 -2.0625 4.796875 -1.71875 4.703125 -1.40625 C 4.609375 -1.101562 4.472656 -0.84375 4.296875 -0.625 C 4.128906 -0.40625 3.921875 -0.234375 3.671875 -0.109375 C 3.429688 0.00390625 3.164062 0.0625 2.875 0.0625 C 2.726562 0.0625 2.597656 0.046875 2.484375 0.015625 C 2.367188 -0.00390625 2.265625 -0.0390625 2.171875 -0.09375 C 2.078125 -0.144531 1.988281 -0.203125 1.90625 -0.265625 C 1.820312 -0.335938 1.75 -0.421875 1.6875 -0.515625 L 1.625 -0.234375 C 1.601562 -0.148438 1.566406 -0.0859375 1.515625 -0.046875 C 1.472656 -0.015625 1.410156 0 1.328125 0 L 0.515625 0 L 0.515625 -6.703125 L 1.75 -6.703125 Z M 1.75 -4.09375 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(66.882206, 15.960062)"><g><path d="M 2.59375 -4.703125 C 2.945312 -4.703125 3.265625 -4.644531 3.546875 -4.53125 C 3.828125 -4.425781 4.070312 -4.269531 4.28125 -4.0625 C 4.488281 -3.851562 4.644531 -3.601562 4.75 -3.3125 C 4.863281 -3.019531 4.921875 -2.691406 4.921875 -2.328125 C 4.921875 -1.953125 4.863281 -1.617188 4.75 -1.328125 C 4.644531 -1.035156 4.488281 -0.785156 4.28125 -0.578125 C 4.070312 -0.367188 3.828125 -0.207031 3.546875 -0.09375 C 3.265625 0.0078125 2.945312 0.0625 2.59375 0.0625 C 2.25 0.0625 1.929688 0.0078125 1.640625 -0.09375 C 1.359375 -0.207031 1.113281 -0.367188 0.90625 -0.578125 C 0.707031 -0.785156 0.550781 -1.035156 0.4375 -1.328125 C 0.320312 -1.617188 0.265625 -1.953125 0.265625 -2.328125 C 0.265625 -2.691406 0.320312 -3.019531 0.4375 -3.3125 C 0.550781 -3.601562 0.707031 -3.851562 0.90625 -4.0625 C 1.113281 -4.269531 1.359375 -4.425781 1.640625 -4.53125 C 1.929688 -4.644531 2.25 -4.703125 2.59375 -4.703125 Z M 2.59375 -0.859375 C 2.945312 -0.859375 3.207031 -0.976562 3.375 -1.21875 C 3.550781 -1.46875 3.640625 -1.832031 3.640625 -2.3125 C 3.640625 -2.789062 3.550781 -3.148438 3.375 -3.390625 C 3.207031 -3.640625 2.945312 -3.765625 2.59375 -3.765625 C 2.238281 -3.765625 1.972656 -3.640625 1.796875 -3.390625 C 1.628906 -3.148438 1.546875 -2.789062 1.546875 -2.3125 C 1.546875 -1.832031 1.628906 -1.46875 1.796875 -1.21875 C 1.972656 -0.976562 2.238281 -0.859375 2.59375 -0.859375 Z M 2.59375 -0.859375 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(72.070356, 15.960062)"><g><path d="M 2.59375 -4.703125 C 2.945312 -4.703125 3.265625 -4.644531 3.546875 -4.53125 C 3.828125 -4.425781 4.070312 -4.269531 4.28125 -4.0625 C 4.488281 -3.851562 4.644531 -3.601562 4.75 -3.3125 C 4.863281 -3.019531 4.921875 -2.691406 4.921875 -2.328125 C 4.921875 -1.953125 4.863281 -1.617188 4.75 -1.328125 C 4.644531 -1.035156 4.488281 -0.785156 4.28125 -0.578125 C 4.070312 -0.367188 3.828125 -0.207031 3.546875 -0.09375 C 3.265625 0.0078125 2.945312 0.0625 2.59375 0.0625 C 2.25 0.0625 1.929688 0.0078125 1.640625 -0.09375 C 1.359375 -0.207031 1.113281 -0.367188 0.90625 -0.578125 C 0.707031 -0.785156 0.550781 -1.035156 0.4375 -1.328125 C 0.320312 -1.617188 0.265625 -1.953125 0.265625 -2.328125 C 0.265625 -2.691406 0.320312 -3.019531 0.4375 -3.3125 C 0.550781 -3.601562 0.707031 -3.851562 0.90625 -4.0625 C 1.113281 -4.269531 1.359375 -4.425781 1.640625 -4.53125 C 1.929688 -4.644531 2.25 -4.703125 2.59375 -4.703125 Z M 2.59375 -0.859375 C 2.945312 -0.859375 3.207031 -0.976562 3.375 -1.21875 C 3.550781 -1.46875 3.640625 -1.832031 3.640625 -2.3125 C 3.640625 -2.789062 3.550781 -3.148438 3.375 -3.390625 C 3.207031 -3.640625 2.945312 -3.765625 2.59375 -3.765625 C 2.238281 -3.765625 1.972656 -3.640625 1.796875 -3.390625 C 1.628906 -3.148438 1.546875 -2.789062 1.546875 -2.3125 C 1.546875 -1.832031 1.628906 -1.46875 1.796875 -1.21875 C 1.972656 -0.976562 2.238281 -0.859375 2.59375 -0.859375 Z M 2.59375 -0.859375 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(77.258506, 15.960062)"><g><path d="M 1.75 -6.703125 L 1.75 -2.890625 L 1.953125 -2.890625 C 2.035156 -2.890625 2.097656 -2.898438 2.140625 -2.921875 C 2.179688 -2.953125 2.226562 -3 2.28125 -3.0625 L 3.296875 -4.421875 C 3.347656 -4.492188 3.40625 -4.546875 3.46875 -4.578125 C 3.539062 -4.609375 3.625 -4.625 3.71875 -4.625 L 4.859375 -4.625 L 3.515625 -2.9375 C 3.410156 -2.800781 3.289062 -2.691406 3.15625 -2.609375 C 3.226562 -2.554688 3.289062 -2.5 3.34375 -2.4375 C 3.394531 -2.375 3.441406 -2.304688 3.484375 -2.234375 L 4.921875 0 L 3.8125 0 C 3.707031 0 3.617188 -0.015625 3.546875 -0.046875 C 3.484375 -0.078125 3.429688 -0.132812 3.390625 -0.21875 L 2.34375 -1.921875 C 2.300781 -1.992188 2.253906 -2.039062 2.203125 -2.0625 C 2.160156 -2.082031 2.097656 -2.09375 2.015625 -2.09375 L 1.75 -2.09375 L 1.75 0 L 0.515625 0 L 0.515625 -6.703125 Z M 1.75 -6.703125 "/></g></g></g></svg>');" onclick="window.open('https://drive.google.com/file/d/1j50r_6WJnAsZh7rYJbjWGvd1f1K6hYHk/view?usp=sharing', '_blank');"></div></td>
        <td style="padding: 10px 20px;"><div style="background-color: lightblue; display: inline-block; border-radius: 4px; cursor: pointer; height: 32px; border: none; width: 123px; background-image: url('data:image/svg+xml;base64,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');" onclick="window.open('https://www.postman.com/satusehat/workspace/satusehat-public/overview', '_blank');"></div></td>
    </tr>
</table>
</div>

## B. Strategi Pengiriman Data ke SATUSEHAT
<div style="margin-left: 30px;">
SATUSEHAT menyediakan dua pilihan cara mengirimkan data use case vaksinasi COVID-19:

### 1. Berbasis Resource
Data dapat dikirimkan secara berurutan sesuai resource yang terlibat pada alur pelayanan terkait. Sebagai contoh: ketika mengirimkan data registrasi kunjungan saja yang berisikan resource Encounter dan QuestionnaireResponse, maka implementor mengirimkan resource-resource tersebut ke SATUSEHAT secara berurutan sesuai dependensinya.

### 2. Berbasis Bundle
Data dapat dikirimkan seluruh resource yang terlibat pada alur pelayanan terkait dengan menggunakan satu langkah pengiriman data ke SATUSEHAT menggunakan profil FHIR bernama Bundle.

Resource-resource yang terlibat di setiap tahapan alur pelayanan untuk use case vaksinasi COVID-19 adalah sebagai berikut:

<style>
.table-fhir-resources {
    border-collapse: collapse;
}
.table-fhir-resources, .table-fhir-resources th, .table-fhir-resources td {
   border: 1px solid black;
}

.table-fhir-resources th, .table-fhir-resources td {
   padding: 5px;
}
</style>

<table class="table-fhir-resources">
<tr>
	<th>Category</th>
	<th>No</th>
	<th>Resource</th>
	<th>Entry Mandatory</th>
</tr>
<tr>
	<td rowspan="5">Base</td>
	<td>1</td>
	<td>Patient</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>2</td>
	<td>Practitioner</td>
	<td><b>Required</b></td>
</tr>

<tr>
	<td>3</td>
	<td>Organization</td>
	<td><b>Required</b></td>
</tr>

<tr>
	<td>4</td>
	<td>Location</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>5</td>
	<td>Encounter *</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td rowspan="8">Clinical</td>
	<td>6</td>
	<td>Condition</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>7</td>
	<td>Observation</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>8</td>
	<td>Immunization</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>9</td>
	<td>QuestionnaireResponse</td>
	<td><b>Required</b></td>
</tr>
</table>

<br>_Notes:_<br>
1. *) Profile Resource yang direkomendasikan tersedia pada proses pencatatan
2. __Required__: Entry resource harus dilibatkan setiap kali mengirimkan bundle
3. _Optional_: Entry resource dapat tidak dilibatkan setiap kali mengirimkan bundle
</div>

## C. Langkah-Langkah Pengiriman Data ke SATUSEHAT

<div style="margin-left: 30px;">

### <b>Informasi Variabel</b>

<p>Variabel serta pemetaan terhadap resource FHIR untuk Pelaporan Vaksinasi COVID-19  yang dipertukarkan dapat dilihat dalam tabel berikut.</p>
<table class="table-fhir-resources">
    <tr>
      <th>No</th>
      <th colspan="2">Variabel</th>
      <th>Resource FHIR</th>
      <th>Path FHIR</th>
    </tr>
    <tr>
      <td>1</td>
      <td colspan="4">Identitas Umum Pasien</td>
    </tr>
    <tr>
      <td rowspan="16"></td>
      <td rowspan="3">a</td>
      <td rowspan="3">Nomor SATUSEHAT Pasien</td>
      <td rowspan="3">Patient</td>
      <td>Patient.identifier[i].use</td>
    </tr>
    <tr>
      <td>Patient.identifier[i].system</td>
    </tr>
    <tr>
      <td>Patient.identifier[i].value</td>
    </tr>
    <tr>
      <td>b</td>
      <td>Nama Lengkap</td>
      <td>Patient</td>
      <td>Patient.name[i].text </td>
    </tr>
    <tr>
      <td rowspan="3">c</td>
      <td rowspan="3">Nomor Rekam Medis</td>
      <td rowspan="3">Patient</td>
      <td>Patient.identifier[i].use</td>
    </tr>
    <tr>
      <td>Patient.identifier[i].system</td>
    </tr>
    <tr>
      <td>Patient.identifier[i].value</td>
    </tr>
    <tr>
      <td rowspan="3">d</td>
      <td rowspan="3">Nomor Induk Kependudukan (NIK)</td>
      <td rowspan="3">Patient</td>
      <td>Patient.identifier[i].use</td>
    </tr>
    <tr>
      <td>Patient.identifier[i].system</td>
    </tr>
    <tr>
      <td>Patient.identifier[i].value</td>
    </tr>
    <tr>
      <td rowspan="3">e</td>
      <td rowspan="3">Nomor Identitas Lain (Khusus WNA): Nomor Paspor / KITAS</td>
      <td rowspan="3">Patient</td>
      <td>Patient.identifier[i].use</td>
    </tr>
    <tr>
      <td>Patient.identifier[i].system</td>
    </tr>
    <tr>
      <td>Patient.identifier[i].value</td>
    </tr>
    <tr>
      <td>f</td>
      <td>Tanggal Lahir</td>
      <td>Patient</td>
      <td>Patient.birthDate</td>
    </tr>
    <tr>
      <td>g</td>
      <td>Jenis Kelamin</td>
      <td>Patient</td>
      <td>Patient.gender</td>
    </tr>
    <tr>
      <td>h</td>
      <td>Alamat Lengkap</td>
      <td>Patient</td>
      <td>Patient.address.line</td>
    </tr>
    <tr>
      <td>2</td>
      <td class="c222" colspan="4">Data Kunjungan</td>
    </tr>
    <tr>
      <td rowspan="5"></td>
      <td>a</td>
      <td>Tanggal &amp; Jam Masuk (Tanggal Kunjungan)</td>
      <td>Encounter</td>
      <td>Encounter.period.start</td>
    </tr>
    <tr>
      <td>b</td>
      <td>Tanggal &amp; Jam Discharge Administrasi</td>
      <td>Encounter</td>
      <td>Encounter.period.end</td>
    </tr>
    <tr>
      <td rowspan="2">c</td>
      <td rowspan="2">Tenaga Kesehatan</td>
      <td rowspan="2">Encounter</td>
      <td>Encounter.participant</td>
    </tr>
    <tr>
      <td>Encounter.participant.type</td>
    </tr>
    <tr>
      <td>d</td>
      <td>Lokasi kunjungan</td>
      <td>Encounter</td>
      <td>Encounter.location</td>
    </tr>
    <tr>
      <td>3</td>
      <td colspan="4">Diagnosis</td>
    </tr>
    <tr>
      <td rowspan="9"></td>
      <td rowspan="9">a</td>
      <td colspan="3">Diagnosis Akhir / Keluar</td>
    </tr>
    <tr>
      <td rowspan="4">1. Diagnosis Primer / Utama</td>
      <td rowspan="3">Encounter</td>
      <td>Encounter.diagnosis.condition</td>
    </tr>
    <tr>
      <td>Encounter.diagnosis.use</td>
    </tr>
    <tr>
      <td>Encounter.diagnosis.rank</td>
    </tr>
    <tr>
      <td>Condition</td>
      <td>Condition.code</td>
    </tr>
    <tr>
      <td rowspan="4">2. Diagnosis Sekunder / Penyerta</td>
      <td rowspan="3">Encounter</td>
      <td>Encounter.diagnosis.condition.code</td>
    </tr>
    <tr>
      <td>Encounter.diagnosis.use</td>
    </tr>
    <tr>
      <td>Encounter.diagnosis.rank</td>
    </tr>
    <tr>
      <td>Condition</td>
      <td>Condition.code</td>
    </tr>
    <tr>
      <td>4</td>
      <td colspan="4">Imunisasi</td>
    </tr>
    <tr>
      <td rowspan="42"></td>
      <td rowspan="3">a</td>
      <td rowspan="3">Jenis Vaksin COVID-19 (Merek)</td>
      <td rowspan="3">Immunization</td>
      <td>Immunization.vaccineCode.coding.system</td>
    </tr>
    <tr>
      <td>Immunization.vaccineCode.coding.code</td>
    </tr>
    <tr>
      <td>Immunization.vaccineCode.coding.display</td>
    </tr>
    <tr>
      <td>b</td>
      <td>Urutan Nomor Dosis Pemberian</td>
      <td>Immunization</td>
      <td>Immunization.protocolApplied.doseNumberPositiveInt</td>
    </tr>
    <tr>
      <td>c</td>
      <td>>Tanggal Pemberian</td>
      <td>Immunization</td>
      <td>Immunization.occurrenceDateTime</td>
    </tr>
    <tr>
      <td>d</td>
      <td>Tanggal Pencatatan</td>
      <td>Immunization</td>
      <td>Immunization.recorded</td>
    </tr>
    <tr>
      <td rowspan="4">e</td>
      <td rowspan="4">Dosis Imunisasi</td>
      <td rowspan="4">Immunization</td>
      <td>Immunization.doseQuantity[0].value[0]</td>
    </tr>
    <tr>
      <td>Immunization.doseQuantity[0].unit[0]</td>
    </tr>
    <tr>
      <td>Immunization.doseQuantity[0].system[0]</td>
    </tr>
    <tr>
      <td>Immunization.doseQuantity[0].code[0]</td>
    </tr>
    <tr>
      <td rowspan="3">f</td>
      <td rowspan="3">Kategori Imunisasi</td>
      <td rowspan="3">Immunization</td>
      <td>Immunization.reasonCode.coding.system</td>
    </tr>
    <tr>
      <td>Immunization.reasonCode.coding.code</td>
    </tr>
    <tr>
      <td>Immunization.reasonCode.coding.display</td>
    </tr>
    <tr>
      <td>g</td>
      <td>Nomor Batch</td>
      <td>Immunization</td>
      <td>Immunization.lotNumber</td>
    </tr>
    <tr>
      <td rowspan="4">h</td>
      <td rowspan="4">Reaksi KIPI</td>
      <td rowspan="4">Immunization</td>
      <td>Immunization.reaction.date</td>
    </tr>
    <tr>
      <td>Immunization.reaction.detail.reference</td>
    </tr>
    <tr>
      <td>Immunization.reaction.detail.display</td>
    </tr>
    <tr>
      <td>Immunization.reaction.reported</td>
    </tr>
    <tr>
      <td>i</td>
      <td>Status Imunisasi</td>
      <td>Immunization</td>
      <td>Immunization.status</td>
    </tr>
    <tr>
      <td>j</td>
      <td>Alasan Tidak DIlakukan Imunisasi</td>
      <td>Immunization</td>
      <td>Immunization.statusReason.coding</td>
    </tr>
    <tr>
      <td>k</td>
      <td>Sumber Data Imunisasi</td>
      <td>Immunization</td>
      <td>Immunization.primarySource<</td>
    </tr>
    <tr>
      <td>l</td>
      <td>Pasien</td>
      <td>Immunization</td>
      <td>Immunization.patient</td>
    </tr>
    <tr>
      <td>m</td>
      <td>Kunjungan Imunisasi</td>
      <td>Immunization</td>
      <td>Immunization.encounter</td>
    </tr>
    <tr>
      <td rowspan="8">n</td>
      <td colspan="3">Tenaga Kesehatan atau Organisasi yang Terlibat dalam Proses Imunisasi</td>
    </tr>
    <tr>
      <td rowspan="3">1) Peran Tenaga Kesehatan dalam Proses Imunisasi</td>
      <td rowspan="3">Immunization</td>
      <td>Immunization.performer.function.system</td>
    </tr>
    <tr>
      <td>Immunization.performer.function.code</td>
    </tr>
    <tr>
      <td>Immunization.performer.function.display</td>
    </tr>
    <tr>
      <td rowspan="2">2) Tenaga Kesehatan yang Terlibat dalam Proses Imunisasi</td>
      <td rowspan="2">Immunization</td>
      <td>Immunization.performer.actor.reference</td>
    </tr>
    <tr>
      <td>Immunization.performer.actor.display</td>
    </tr>
    <tr>
      <td rowspan="2">3) Organisasi Induk yang Terlibat dalam Proses Imunisasi</td>
      <td rowspan="2">Immunization</td>
      <td>Immunization.performer.actor.reference</td>
    </tr>
    <tr>
      <td>Immunization.performer.actor.display</td>
    </tr>
    <tr>
      <td rowspan="3">o</td>
      <td rowspan="3">Rute Pemberian Imunisasi</td>
      <td rowspan="3">Immunization</td>
      <td>Immunization.route.coding.system</td>
    </tr>
    <tr>
      <td>Immunization.route.coding.code</td>
    </tr>
    <tr>
      <td>Immunization.route.coding.display</td>
    </tr>
    <tr>
      <td rowspan="3">p</td>
      <td rowspan="3">Kategori Penerima Vaksin COVID-19</td>
      <td rowspan="3">Observation</td>
      <td>Observation.code</td>
    </tr>
    <tr>
      <td>Observation.category</td>
    </tr>
    <tr>
      <td>Observation.valueCodeableConcept</td>
    </tr>
    <tr>
      <td rowspan="3">q</td>
      <td rowspan="3">Subkategori Penerima Vaksin COVID-19</td>
      <td rowspan="3">Observation</td>
      <td>Observation.code</td>
    </tr>
    <tr>
      <td>Observation.category</td>
    </tr>
    <tr>
      <td>Observation.valueCodeableConcept</td>
    </tr>
    <tr>
      <td>r</td>
      <td>Pendanaan Vaksin</td>
      <td>Immunization</td>
      <td>Immunization.fundingSource.coding</td>
    </tr>
    <tr>
      <td>s</td>
      <td>Keterangan</td>
      <td>Immunization</td>
      <td>Immunization.note.text</td>
    </tr>
    <tr>
      <td>6</td>
      <td class="c198" colspan="4">Gejala Kejadian Ikutan Pasca Imunisasi (KIPI)</td>
    </tr>
    <tr>
      <td rowspan="3"></td>
      <td rowspan="3">a</td>
      <td rowspan="3">Gejala KIPI</td>
      <td rowspan="3">Observation</td>
      <td>Observation.code</td>
    </tr>
    <tr>
      <td>Observation.category</td>
    </tr>
    <tr>
      <td>Observation.valueCodeableConcept</td>
    </tr>
</table>

### <div id="SearchPatientPractitionerOrganization" style="font-weight: bold;">Pre-Use Case Requirement</div>

<div style="margin-left: 30px;">
<h4 style="font-weight: bold;">Registrasi Struktur Organisasi</h4>
<p>Data fasyankes yang melaporkan vaksinasi COVID-19 tidak perlu diikutsertakan dalam bundle data yang dikirim karena data sudah tersedia pada *Master Sarana Index* yang ada di SATUSEHAT.</p>

> `CATATAN:`
>  Informasi terkait pemetaan nilai, penjelasan tipe mandatoris, deskripsi dan format pengisian dari setiap elemen data/path di dalam resource Organization (data suborganisasi), dapat dilihat dalam resource <a href="https://satusehat.kemkes.go.id/platform/docs/id/fhir/resources/organization/#organization">Organization</a>.

<h4 style="font-weight: bold;">Registrasi Struktur Lokasi</h4>
<p>Data lokasi fasyankes seperti alamat, provinsi, dsb tidak perlu diikutsertakan dalam bundle data yang dikirim karena data sudah tersedia pada *Master Sarana Index* yang ada di SATUSEHAT.</p>

> `CATATAN:`
>  Informasi terkait pemetaan nilai, penjelasan tipe mandatoris, deskripsi dan format pengisian dari setiap elemen data/path di dalam resource Location (data sublokasi), dapat dilihat dalam resource <a href="https://satusehat.kemkes.go.id/platform/docs/id/fhir/resources/location/#location">Location</a>.

<h4 style="font-weight: bold;">Nomor IHS untuk Tenaga Kesehatan</h4>
<p>Data identitas nakes yang mengisi data laporan vaksinasi COVID-19 tidak perlu dikirimkan karena sudah tersedia di *Master Nakes Index* yang ada di SATUSEHAT.</p>

> `CATATAN:`
>  Informasi terkait pemetaan nilai, penjelasan tipe mandatoris, deskripsi dan format pengisian dari setiap elemen data/path di dalam resource Practitioner (data nomor IHS Tenaga Kesehatan), dapat dilihat dalam resource  <a href="https://satusehat.kemkes.go.id/platform/docs/id/fhir/resources/practitioner/#practitioner">Practitioner</a>.

Proses pencarian data fasyankes dan nakes dapat dilakukan melalui FHIR API dengan metode GET dengan parameter dibawah ini:

| No  | Data        | Resource      | Parameter Pencarian             |
| --- |------------ | ------------- | --------------------------------|
| 1   | Fasyankes   | Organization  | Fasyankes SATUSEHAT Number      |
| 2   | Lokasi      | Location      | SATUSEHAT Location ID           |
| 3   | Nakes       | Practitioner  | NIK, Nakes SATUSEHAT Number     |
</div>

### <div id="step1" style="font-weight: bold;">1. Pendaftaran Pasien</div>
<div style="margin-left: 30px;">
<p>Apabila melakukan pengiriman data kesehatan melalui SATUSEHAT yang memiliki elemen data terkait pasien, maka diperlukan informasi {patient-ihs-number} dari pasien yang bersangkutan. {patient-ihs-number} seorang pasien didapatkan dari Master Patient Index (MPI) Kementerian Kesehatan. MPI menyimpan data-data demografi pasien berskala nasional, mulai dari nama, tanggal lahir, alamat, Identitas resmi yang diterbitkan pemerintah, dan lain lain. Setelah mendapatkan {patient-ihs-number}, ID dapat disimpan secara di masing-masing sistem internal fasyankes maupun partner non-fasyankes. {patient-ihs-number} akan mempermudah pelaporan pelayanan kesehatan yang berhubungan dengan pasien, karena partner tidak diwajibkan menyertakan data diri setiap ada pengiriman data {patient-ihs-number} juga dapat digunakan untuk melihat data diri pasien secara menyeluruh.</p>

<p>Proses pencarian {patient-ihs-number} dari pasien dapat dilakukan melalui FHIR API dengan metode GET. Untuk metode pencarian data pasien di SATUSEHAT secara detail dapat dilihat dalam dokumen <a href="https://docs.google.com/document/d/1wGsuxUJcmWsGhTdAthe0pmcnsqtggLlQdFUG5fU4_T4/edit#heading=h.4fzggw2guay3">Petunjuk Teknis SATUSEHAT (Juknis SATSET)</a>.</p>
</div>

### <div id="step2" style="font-weight: bold;">2. Pendaftaran Kunjungan Pasien</div>
<div style="margin-left: 30px;">
<p>Kunjungan pasien dapat didefinisikan sebagai interaksi pasien terhadap suatu layanan fasyankes. Sebagai contoh, dalam satu rangkaian rawat jalan, seluruh rangkaian dapat didefinisikan sebagai satu Encounter. Data-data kunjungan pasien yang direkam meliputi kapan pertemuan tersebut mulai dan selesai, siapa tenaga kesehatan yang melayani, siapa subjek dari pelayanannya, dan informasi pendukung lainnya.</p>

<p>Pemetaan nilai serta pemetaan variabel dan terminologi spesifik terkait Pendaftaran Kunjungan Pasien dapat merujuk ke modul pelayanan yang terkait, baik <a href="https://satusehat.kemkes.go.id/platform/docs/id/interoperability/">Modul Rawat Jalan, IGD, maupun Rawat Inap di SATUSEHAT</a>.</p>

<!--Part 1-1 Variable Pendataan Kunjungan-->
<details>
	<summary>
		<h4>&#10133; Pendataan Kunjungan Rawat Jalan</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-1-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-1-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-1-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-1-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-1-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Encounter-Create-PendataanKunjungan}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-1-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Encounter",
    "identifier":  [
        {
            "system": "http://sys-ids.kemkes.go.id/encounter/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "arrived",
    "class": {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "IMMUNIZ",
        "display": "Immunization"
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "participant":  [
        {
            "type":  [
                {
                    "coding":  [
                        {
                            "system": "http://terminology.hl7.org/CodeSystem/v3-ParticipationType",
                            "code": "ATND",
                            "display": "attender"
                        }
                    ]
                }
            ],
            "individual": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "period": {
        "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>"
    },
    "location":  [
        {
            "location": {
                "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_ID&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "statusHistory":  [
        {
            "status": "arrived",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>",
                "end": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_END&rcub;&rcub;</strong>"
            }
        }
    ],
    "serviceProvider": {
        "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>"
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-1-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                   | Deskripsi |
| ---------------------------| --------- |
| __ENCOUNTER_LOCAL_CODE__   | ID Lokal untuk Kunjungan/Encounter |
| __PATIENT_IHS_NUMBER__     | SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __DOCTOR_IHS_NUMBER__      | SATUSEHAT ID untuk Dokter/Nakes |
| __DOCTOR_NAME__            | Nama Dokter/Nakes |
| __FACILITY_IHS_NUMBER__    | SATUSEHAT ID untuk FASYANKES |
| __ENCOUNTER_PERIOD1_START__| Waktu mulai/check-in kunjungan |
| __ENCOUNTER_PERIOD1_END__  | Waktu mulai/check-out kunjungan |
| __ENCOUNTER_LOCATION_ID__  | ID Location tempat kunjungan dilakukan |
| __ENCOUNTER_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-1-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
<br>
</details>
<!--ENDPart1-1-->

<!--Part 1-2-->
<details>
	<summary>
		<h4>&#10133; Masuk ke ruang pemeriksaan</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-1-2" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-1-2" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-1-2" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-1-2" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-1-2">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">{{json:covid/vaksin/Encounter-Create-InProgress.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-1-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Encounter",
    "identifier":  [
        {
            "system": "http://sys-ids.kemkes.go.id/encounter/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "arrived",
    "class": {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "IMMUNIZ",
        "display": "Immunization"
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "participant":  [
        {
            "type":  [
                {
                    "coding":  [
                        {
                            "system": "http://terminology.hl7.org/CodeSystem/v3-ParticipationType",
                            "code": "ATND",
                            "display": "attender"
                        }
                    ]
                }
            ],
            "individual": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "period": {
        "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>"
    },
    "location":  [
        {
            "location": {
                "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_ID&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "statusHistory":  [
        {
            "status": "arrived",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>",
                "end": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_END&rcub;&rcub;</strong>"
            }
        }
    ],
    "serviceProvider": {
        "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>"
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-1-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>

| Variabel                   | Deskripsi |
| ---------------------------| --------- |
| __ENCOUNTER_LOCAL_CODE__   | ID Lokal untuk Kunjungan/Encounter |
| __PATIENT_IHS_NUMBER__     | SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __DOCTOR_IHS_NUMBER__      | SATUSEHAT ID untuk Dokter/Nakes |
| __DOCTOR_NAME__            | Nama Dokter/Nakes |
| __FACILITY_IHS_NUMBER__    | SATUSEHAT ID untuk FASYANKES |
| __ENCOUNTER_PERIOD1_START__| Waktu mulai/check-in kunjungan |
| __ENCOUNTER_PERIOD1_END__  | Waktu mulai/check-out kunjungan |
| __ENCOUNTER_LOCATION_ID__  | ID Location tempat kunjungan dilakukan |
| __ENCOUNTER_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"

</div>
</div>

<div role="tabpanel" class="tab-pane" id="valueset-1-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
<br>
</details>
<!--ENDPart1-2-->
</div>
<!--ENDPart1-->


<!--Part3-->
### <div id="step3" style="font-weight: bold;">3. Kategori & Subkategori Penerima Vaksin COVID-19</div>

<div style="margin-left: 30px;">
<!--Part 3-1 Variable Pendataan Kelompok Penerima-->
<details>
	<summary>
<h4>&#10133; Kategori Penerima Vaksin COVID-19</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-3-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-3-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-3-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-3-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-3-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-KelompokPenerima}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "identifier": [
        {
            "system": "http://sys-ids.kemkes.go.id/observation/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
                    "code": "survey",
                    "display": "Survey"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://terminology.kemkes.go.id/CodeSystem/clinical-term",
                "code": "OC000133",
                "display": "Kategori Penerima Vaksin COVID-19"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
    "performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "valueCodeableConcept": {
        "coding": [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_SYSTEM&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_CODE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_DISPLAY&rcub;&rcub;</strong>"
            }
        ]
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __FACILITY_IHS_NUMBER__   			| SATUSEHAT ID untuk FASYANKES |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| SATUSEHAT ID Number untuk Pasien |
| __ENCOUNTER_REFERENCE_ID__      		| SATUSEHAT ID Number untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __DOCTOR_IHS_NUMBER__    				| SATUSEHAT ID untuk Dokter/Nakes |
| __OBSERVATION_VALUE__          		| __(*)__ Nilai observasi, referensi ke value set "Kategori Kelompok Penerima Vaksin" |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

<div>Kategori Kelompok Penerima Vaksin</div>

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | 223366009 | Healthcare professional | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 2 | OV000325 | Pelayan Publik | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 3 | 105436006 | Elderly person | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 4 | 133936004 | Adult | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 5 | 133937008 | Adolescent | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 6 | 410601007 | Childhood age person | [http://snomed.info/sct](http://snomed.info/sct)  |
| 7 | OV000326 | Diplomat | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 8 | OV000327 | Gotong Royong | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |



</div>
</div>
<br>
</details>
<!--ENDPart3-1-->

<!--Part 3-2 Variable Pendataan Kategori Penerima-->
<details>
	<summary>
<h4>&#10133; Subkategori Penerima Vaksin COVID-19</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-3-2" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-3-2" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-3-2" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-3-2" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-3-2">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-KategoriPenerima}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-3-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "identifier": [
        {
            "system": "http://sys-ids.kemkes.go.id/observation/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
                    "code": "survey",
                    "display": "Survey"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://terminology.kemkes.go.id/CodeSystem/clinical-term",
                "code": "OC000134",
                "display": "Subkategori Penerima Vaksin COVID-19"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
    "performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "valueCodeableConcept": {
        "coding": [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_SYSTEM&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_CODE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_DISPLAY&rcub;&rcub;</strong>"
            }
        ]
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-3-2" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __FACILITY_IHS_NUMBER__   			| SATUSEHAT ID untuk FASYANKES |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| SATUSEHAT ID Number untuk Pasien |
| __ENCOUNTER_REFERENCE_ID__      		| SATUSEHAT ID Number untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __DOCTOR_IHS_NUMBER__    				| SATUSEHAT ID untuk Dokter/Nakes |
| __OBSERVATION_VALUE__          		| __(*)__ Nilai observasi, referensi ke value set "Subkategori Kelompok Penerima Vaksin" |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-3-2" style="border: 1px solid #e8edee; padding: 15px 10px;">

<div>Subkategori Kelompok Penerima Vaksin</div>

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | 410601007 | Childhood age person | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 2 | 106325008 | Athlete, sportsman AND/OR related worker | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 3 | OV000328 | BUMD | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 4 | OV000329 | BUMN | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 5 | OV000330 | Disabilitas Lainnya | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 6 | OV000331 | Disabilitas Mental | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 7 | 255409004 | Pregnant woman | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 8 | OV000332 | Ibu Menyusui | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 9 | 308199006 | Security services occupation | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 10 | 105436006 | Elderly person | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 11 | OV000333 | Masyarakat Lainnya | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 12 | 417430008 | Vulnerable adult | [http://snomed.info/sct](http://snomed.info/sct)  |
| 13 | OV000334 | Masyarakat Umum | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 14 | OV000335 | Pariwisata | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 15 | OV000336 | Pedagang Pasar | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 16 | OV000337 | Pegawai Pemerintah | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 17 | OV000338 | Pejabat Negara | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 18 | OV000339 | Pelayan Publik | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 19 | OV000340 | Pendamping Disabilitas | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 20 | OV000341 | Pendidik | http://terminology.kemkes.go.id/CodeSystem/clinical-term  |
| 21 | OV000342 | Penyuluh Agama | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 22 | 159465002 | Police/prison/fire officers | [http://snomed.info/sct](http://snomed.info/sct)  |
| 23 | OV000343 | Pra-Lansia | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 24 | 133937008 | Adolescent | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 25 | 223366009 | Healthcare professional | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 26 | 302314004 | Military personnel | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 27 | OV000344 | Transportasi Publik | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 28 | 428024001 | Clinical trial participant | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 29 | OV000345 | Wakil Rakyat | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 30 | 51764002 | Reporter | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 31 | OV000346 | WNA(PNA/OI) | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |

</div>
</div>
<br>
</details>
<!--ENDPart3-2-->
</div>

### <div id="step4" style="font-weight: bold;">4. Vaksinasi COVID-19 dan Gejala KIPI</div>

<div style="margin-left: 30px;">
<p>Pengiriman data tindakan imunisasi dan riwayat imunisasi dilakukan melalui resource Immunization.</p>

<p>Pemetaan nilai resource Immunization, tipe mandatoris, deskripsi, dan format pengisian dari setiap elemen data/path dapat merujuk ke <a href="https://satusehat.kemkes.go.id/platform/docs/id/interoperability/imunisasi-new/">Modul Imunisasi</a>. Untuk contoh pengiriman data atau payload dari Immunization dapat dilihat dalam <a href="http://s.id/PostmanSATUSEHAT">Postman Collection</a>.</p>

<!--Part 2-1-->
<details>
	<summary>
<h4>&#10133; a. Imunisasi dilakukan oleh Nakes</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-2-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-2-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-2-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-2-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-2-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Immunization-Create-Imunisasi-Complete-ByNakes-1.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-2-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
	"statusReason": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "expirationDate": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_EXPIRATIONDATE&rcub;&rcub;</strong>",
    "primarySource": true,
    "location": {
        "reference": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_ID&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "lotNumber": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_BATCH_NO&rcub;&rcub;</strong>",
    "route": {
        "coding":  [
            {
                "system": "http://www.whocc.no/atc",
                "code": "inj.intramuscular",
                "display": "Injection Intramuscular"
            }
        ]
    },
    "doseQuantity": {
        "value": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_QTY&rcub;&rcub;</strong>",
        "unit": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>",
        "system": "http://unitsofmeasure.org",
        "code": "color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/N10000001"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>"
                }
            ]
        }
    ],
    "fundingSource": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>"
            }
        ]
    },
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-2-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      			| SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __VACCINE_STATUS_REASON__    | __(*)__ Berisi data alasan yang menyebabkan tidak dilakukannya vaksinasi. Referensi ke value set "Alasan Tidak Dilakukan Imunisasi"|
| __ENCOUNTER_REFERENCE_ID__      		| SATUSEHAT ID Number untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_EXPIRATIONDATE__     | Tanggal kadaluarsa vaksin yang diberikan dengan tipe data date dalam format YYYY-MM-DD |
| __FACILITY_IHS_NUMBER__    | SATUSEHAT ID untuk FASYANKES |
| __IMMUNIZATION_LOCATION_ID__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_BATCH_NO__| Nomor batch vaksin yang diberikan dengan tipe data string |
| __IMMUNIZATION_DOSE_QTY__| Jumlah dosis vaksinasi yang diberikan dalam 1 pemberian dengan tipe data SimpleQuantity. |
| __IMMUNIZATION_DOSE_UNIT__| Satuan dosis vaksinasi yang diberikan dalam 1 pemberian |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __DOCTOR_IHS_NUMBER__      | SATUSEHAT ID untuk Dokter/Nakes |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_FUNDING__| __(*)__ Sumber pembiayaan imunisasi/vaksin yang diberikan dengan tipe data CodeableConcept. Referensi ke value set "Pendanaan Vaksin" |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-2-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

##### Jenis Vaksin COVID-19
| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Pendanaan Vaksin

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | IF000001 | Vaksin Gotong Royong | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |
| 2 | IF000002 | Vaksin Program | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
<br>
</details>
<!--ENDPart2-1-->

<!--Part 2-2-->
<details>
<summary>
<h4>&#10133; b. Imunisasi ditunda karena kondisi klinis (Tunda)</h4>
</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-2-2" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-2-2" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-2-2" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-2-2" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-2-2">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Immunization-Create-Imunisasi-Tunda.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-2-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
	"statusReason": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "expirationDate": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_EXPIRATIONDATE&rcub;&rcub;</strong>",
    "primarySource": true,
    "location": {
        "reference": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_ID&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "lotNumber": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_BATCH_NO&rcub;&rcub;</strong>",
    "route": {
        "coding":  [
            {
                "system": "http://www.whocc.no/atc",
                "code": "inj.intramuscular",
                "display": "Injection Intramuscular"
            }
        ]
    },
    "doseQuantity": {
        "value": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_QTY&rcub;&rcub;</strong>",
        "unit": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>",
        "system": "http://unitsofmeasure.org",
        "code": "color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/N10000001"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>"
                }
            ]
        }
    ],
    "fundingSource": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>"
            }
        ]
    },
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-2-2" style="border: 1px solid #e8edee; padding: 15px 10px;">


| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      			| SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __VACCINE_STATUS_REASON__    | __(*)__ Berisi data alasan yang menyebabkan tidak dilakukannya vaksinasi. Referensi ke value set "Alasan Tidak Dilakukan Imunisasi"|
| __ENCOUNTER_REFERENCE_ID__      		| SATUSEHAT ID Number untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_EXPIRATIONDATE__     | Tanggal kadaluarsa vaksin yang diberikan dengan tipe data date dalam format YYYY-MM-DD |
| __FACILITY_IHS_NUMBER__    | SATUSEHAT ID untuk FASYANKES |
| __IMMUNIZATION_LOCATION_ID__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_BATCH_NO__| Nomor batch vaksin yang diberikan dengan tipe data string |
| __IMMUNIZATION_DOSE_QTY__| Jumlah dosis vaksinasi yang diberikan dalam 1 pemberian dengan tipe data SimpleQuantity. |
| __IMMUNIZATION_DOSE_UNIT__| Satuan dosis vaksinasi yang diberikan dalam 1 pemberian |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __DOCTOR_IHS_NUMBER__      | SATUSEHAT ID untuk Dokter/Nakes |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_FUNDING__| __(*)__ Sumber pembiayaan imunisasi/vaksin yang diberikan dengan tipe data CodeableConcept. Referensi ke value set "Pendanaan Vaksin" |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-2-2" style="border: 1px solid #e8edee; padding: 15px 10px;">

##### Jenis Vaksin COVID-19
| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Pendanaan Vaksin

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | IF000001 | Vaksin Gotong Royong | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |
| 2 | IF000002 | Vaksin Program | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
<br>
</details>
<!--ENDPart2-2-->


<!--Part 2-3-->
<details>
	<summary>
<h4>&#10133; c. Imunisasi tidak jadi dilakukan (Tidak Vaksin)</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-2-3" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-2-3" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-2-3" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-2-3" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-2-3">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Immunization-Create-Imunisasi-TidakVaksin.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-2-3" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
	"statusReason": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "expirationDate": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_EXPIRATIONDATE&rcub;&rcub;</strong>",
    "primarySource": true,
    "location": {
        "reference": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_ID&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "lotNumber": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_BATCH_NO&rcub;&rcub;</strong>",
    "route": {
        "coding":  [
            {
                "system": "http://www.whocc.no/atc",
                "code": "inj.intramuscular",
                "display": "Injection Intramuscular"
            }
        ]
    },
    "doseQuantity": {
        "value": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_QTY&rcub;&rcub;</strong>",
        "unit": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>",
        "system": "http://unitsofmeasure.org",
        "code": "color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/N10000001"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                       "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>"
                }
            ]
        }
    ],
    "fundingSource": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>"
            }
        ]
    },
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-2-3" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      			| SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __VACCINE_STATUS_REASON__    | __(*)__ Berisi data alasan yang menyebabkan tidak dilakukannya vaksinasi. Referensi ke value set "Alasan Tidak Dilakukan Imunisasi"|
| __ENCOUNTER_REFERENCE_ID__      		| SATUSEHAT ID Number untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_EXPIRATIONDATE__     | Tanggal kadaluarsa vaksin yang diberikan dengan tipe data date dalam format YYYY-MM-DD |
| __FACILITY_IHS_NUMBER__    | SATUSEHAT ID untuk FASYANKES |
| __IMMUNIZATION_LOCATION_ID__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_BATCH_NO__| Nomor batch vaksin yang diberikan dengan tipe data string |
| __IMMUNIZATION_DOSE_QTY__| Jumlah dosis vaksinasi yang diberikan dalam 1 pemberian dengan tipe data SimpleQuantity. |
| __IMMUNIZATION_DOSE_UNIT__| Satuan dosis vaksinasi yang diberikan dalam 1 pemberian |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __DOCTOR_IHS_NUMBER__      | SATUSEHAT ID untuk Dokter/Nakes |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_FUNDING__| __(*)__ Sumber pembiayaan imunisasi/vaksin yang diberikan dengan tipe data CodeableConcept. Referensi ke value set "Pendanaan Vaksin" |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-2-3" style="border: 1px solid #e8edee; padding: 15px 10px;">

##### Jenis Vaksin COVID-19
| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Pendanaan Vaksin

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | IF000001 | Vaksin Gotong Royong | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |
| 2 | IF000002 | Vaksin Program | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
<br>
</details>
<!--ENDPart2-3-->


<!--Part 2-4-->
<details>
	<summary>
<h4>&#10133; d. Imunisasi dilakukan oleh Nakes dilaporkan KIPI oleh Nakes</h4>
    </summary>

<h5>Imunisasi</h5>
<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-2-4" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-2-4" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-2-4" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-2-4" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-2-4">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Immunization-Create-Imunisasi-Complete-ByNakes-2.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-2-4" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
	"statusReason": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "expirationDate": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_EXPIRATIONDATE&rcub;&rcub;</strong>",
    "primarySource": true,
    "location": {
        "reference": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_ID&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "lotNumber": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_BATCH_NO&rcub;&rcub;</strong>",
    "route": {
        "coding":  [
            {
                "system": "http://www.whocc.no/atc",
                "code": "inj.intramuscular",
                "display": "Injection Intramuscular"
            }
        ]
    },
    "doseQuantity": {
        "value": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_QTY&rcub;&rcub;</strong>",
        "unit": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>",
        "system": "http://unitsofmeasure.org",
        "code": "color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/N10000001"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>"
                }
            ]
        }
    ],
    "fundingSource": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>"
            }
        ]
    },
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-2-4" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      			| SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __VACCINE_STATUS_REASON__    | __(*)__ Berisi data alasan yang menyebabkan tidak dilakukannya vaksinasi. Referensi ke value set "Alasan Tidak Dilakukan Imunisasi"|
| __ENCOUNTER_REFERENCE_ID__      		| SATUSEHAT ID Number untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_EXPIRATIONDATE__     | Tanggal kadaluarsa vaksin yang diberikan dengan tipe data date dalam format YYYY-MM-DD |
| __FACILITY_IHS_NUMBER__    | SATUSEHAT ID untuk FASYANKES |
| __IMMUNIZATION_LOCATION_ID__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_BATCH_NO__| Nomor batch vaksin yang diberikan dengan tipe data string |
| __IMMUNIZATION_DOSE_QTY__| Jumlah dosis vaksinasi yang diberikan dalam 1 pemberian dengan tipe data SimpleQuantity. |
| __IMMUNIZATION_DOSE_UNIT__| Satuan dosis vaksinasi yang diberikan dalam 1 pemberian |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __DOCTOR_IHS_NUMBER__      | SATUSEHAT ID untuk Dokter/Nakes |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_FUNDING__| __(*)__ Sumber pembiayaan imunisasi/vaksin yang diberikan dengan tipe data CodeableConcept. Referensi ke value set "Pendanaan Vaksin" |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-2-4" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>

##### Jenis Vaksin COVID-19
| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Pendanaan Vaksin

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | IF000001 | Vaksin Gotong Royong | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |
| 2 | IF000002 | Vaksin Program | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
</div>
<br>
<!--ENDPart2-4-->


<!--Part 2-5-->
<h5>KIPI terpantau Nakes</h5>
<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-2-5" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-2-5" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-2-5" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-2-5" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-2-5">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-KIPI-Malaise}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-2-5" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "identifier": [
        {
            "system": "http://sys-ids.kemkes.go.id/observation/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
                    "code": "exam",
                    "display": "Exam"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
               "system": "http://loinc.org",
                "code": "31044-1",
                "display": "Immunization reaction"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
    "performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "valueCodeableConcept": {
        "coding": [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_SYSTEM&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_CODE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE_DISPLAY&rcub;&rcub;</strong>"
            }
        ]
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-2-5" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __FACILITY_IHS_NUMBER__   			| SATUSEHAT ID untuk FASYANKES |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| SATUSEHAT ID Number untuk Pasien |
| __ENCOUNTER_REFERENCE_ID__      		| SATUSEHAT ID Number untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __DOCTOR_IHS_NUMBER__    				| SATUSEHAT ID untuk Dokter/Nakes |
| __OBSERVATION_VALUE__          		| Nilai observasi |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-2-5" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
<br>
</details>
<!--ENDPart2-5-->

<!--Part 2-6-->
<details>
	<summary>
<h4>&#10133; e. Riwayat Vaksinasi dilaporkan oleh Kader</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-2-6" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-2-6" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-2-6" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-2-6" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-2-6">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Immunization-Create-Imunisasi-Complete-ByKader}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-2-6" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
	"statusReason": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "expirationDate": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_EXPIRATIONDATE&rcub;&rcub;</strong>",
    "primarySource": true,
    "location": {
        "reference": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_ID&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "lotNumber": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_BATCH_NO&rcub;&rcub;</strong>",
    "route": {
        "coding":  [
            {
                "system": "http://www.whocc.no/atc",
                "code": "inj.intramuscular",
                "display": "Injection Intramuscular"
            }
        ]
    },
    "doseQuantity": {
        "value": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_QTY&rcub;&rcub;</strong>",
        "unit": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>",
        "system": "http://unitsofmeasure.org",
        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/N10000001"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>"
                }
            ]
        }
    ],
    "fundingSource": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_FUNDING&rcub;&rcub;</strong>"
            }
        ]
    },
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-2-6" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      			| SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __VACCINE_STATUS_REASON__    | __(*)__ Berisi data alasan yang menyebabkan tidak dilakukannya vaksinasi. Referensi ke value set "Alasan Tidak Dilakukan Imunisasi"|
| __ENCOUNTER_REFERENCE_ID__      		| SATUSEHAT ID Number untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY, YYYY-MM, YYYY-MM-DD atau YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_EXPIRATIONDATE__     | Tanggal kadaluarsa vaksin yang diberikan dengan tipe data date dalam format YYYY-MM-DD |
| __FACILITY_IHS_NUMBER__    | SATUSEHAT ID untuk FASYANKES |
| __IMMUNIZATION_LOCATION_ID__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_BATCH_NO__| Nomor batch vaksin yang diberikan dengan tipe data string |
| __IMMUNIZATION_DOSE_QTY__| Jumlah dosis vaksinasi yang diberikan dalam 1 pemberian dengan tipe data SimpleQuantity. |
| __IMMUNIZATION_DOSE_UNIT__| Satuan dosis vaksinasi yang diberikan dalam 1 pemberian |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __DOCTOR_IHS_NUMBER__      | SATUSEHAT ID untuk Dokter/Nakes |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_FUNDING__| __(*)__ Sumber pembiayaan imunisasi/vaksin yang diberikan dengan tipe data CodeableConcept. Referensi ke value set "Pendanaan Vaksin" |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-2-6" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>


##### Jenis Vaksin COVID-19 

| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Pendanaan Vaksin

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | IF000001 | Vaksin Gotong Royong | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |
| 2 | IF000002 | Vaksin Program | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
</div>
<br>
</details>
<!--ENDPart2-6-->
</div>
<!--ENDPart2-->

### <div id="step5" style="font-weight: bold;">5. Diagnosis</div>

<div style="margin-left: 30px;">
<p>Data diagnosis pasien dapat dikirimkan menggunakan resource Condition. Informasi diagnosis yang dimiliki pasien dilaporkan menggunakan kode ICD-10. Satu payload Condition hanya dapat digunakan untuk melaporkan 1 kode ICD-10. Sehingga apabila pasien memiliki 2 diagnosis, maka dikirimkan 2 payload Condition dengan 2 kode ICD-10 yang berbeda.</p>

<!--Part 4-1 Variable Pencatatan Diagnosis-->
<details>
	<summary>
<h4>&#10133; Pencatatan Diagnosis</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-4-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-4-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-4-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-4-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-4-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Condition-Create-PencatatanDiagnosis}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-4-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Condition",
    "clinicalStatus": {
        "coding": [
            {
                "system": "http://terminology.hl7.org/CodeSystem/condition-clinical",
                "code": "active",
                "display": "Active"
            }
        ]
    },
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/condition-category",
                    "code": "encounter-diagnosis",
                    "display": "Encounter Diagnosis"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://hl7.org/fhir/sid/icd-10",
                "code": "U11.9",
                "display": "Need for immunization against COVID-19, unspecified"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_REFERENCE_ID&rcub;&rcub;</strong>"
    },
    "onsetDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;CONDITION_ONSET_DATETIME&rcub;&rcub;</strong>",
    "recordedDate": "<strong style="color:#00a7ff">&lcub;&lcub;CONDITION_RECORDED_DATETIME&rcub;&rcub;</strong>"
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-4-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      | SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __CONDITION_ONSET_DATETIME__ | Tanggal perkiraan atau tanggal aktual atau tanggal-waktu kondisi mulai, menurut pendapat dokter.|
| __CONDITION_RECORDED_DATETIME__ | 	Tanggal kapan kondisi/keluhan ini tercatat dalam sistem (tanggal yang dibuat oleh sistem)|

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-4-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
<br>
</details>
</div>
<!--ENDPart4-1-->

<!--Part 4-2 Variable Pasien Pulang-->
### <div id="step6" style="font-weight: bold;">6. Update Kunjungan</div>

<div style="margin-left: 30px;">
<p>Setelah mendapatkan vaksinasi COVID-19, individu dapat pulang. Status kunjungan individu pada saat pulang direkam dengan menggunakan resource Encounter.</p>

<details>
	<summary>
		<h4>&#10133; Update Finished + Diagnosis</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-4-2" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-4-2" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-4-2" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-4-2" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-4-2">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Encounter-Update-PasienPulang.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-4-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Encounter",
    "identifier":  [
        {
            "system": "http://sys-ids.kemkes.go.id/encounter/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "arrived",
    "class": {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "IMMUNIZ",
        "display": "Immunization"
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "participant":  [
        {
            "type":  [
                {
                    "coding":  [
                        {
                            "system": "http://terminology.hl7.org/CodeSystem/v3-ParticipationType",
                            "code": "ATND",
                            "display": "attender"
                        }
                    ]
                }
            ],
            "individual": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_IHS_NUMBER&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "period": {
        "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>"
    },
    "location":  [
        {
            "location": {
                "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_ID&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "statusHistory":  [
        {
            "status": "arrived",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>",
                "end": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_END&rcub;&rcub;</strong>"
            }
        }
    ],
    "serviceProvider": {
        "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;FACILITY_IHS_NUMBER&rcub;&rcub;</strong>"
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-4-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>

| Variabel                   | Deskripsi |
| ---------------------------| --------- |
| __ENCOUNTER_LOCAL_CODE__   | ID Lokal untuk Kunjungan/Encounter |
| __PATIENT_IHS_NUMBER__     | SATUSEHAT ID Number untuk Pasien |
| __PATIENT_NAME__           | Nama Pasien |
| __DOCTOR_IHS_NUMBER__      | SATUSEHAT ID untuk Dokter/Nakes |
| __DOCTOR_NAME__            | Nama Dokter/Nakes |
| __FACILITY_IHS_NUMBER__    | SATUSEHAT ID untuk FASYANKES |
| __ENCOUNTER_PERIOD1_START__| Waktu mulai/check-in kunjungan |
| __ENCOUNTER_PERIOD1_END__  | Waktu mulai/check-out kunjungan |
| __ENCOUNTER_LOCATION_ID__  | ID Location tempat kunjungan dilakukan |
| __ENCOUNTER_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>
</div>

<div role="tabpanel" class="tab-pane" id="valueset-4-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
</details>
<br>
<!--ENDPart4-2-->
</div>
</div>